RADX

Radiopharm Theranostics Limited
D

RADX

1.09000
USD
-0.04
(-3.54%)
مفتوح الان
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
2,423
الربح لكل سهم
-4
العائد الربحي
-
P/E
-0
حجم السوق
15,905,097
أصول ذات صلة

العنوان: Radiopharm Theranostics Limited

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Radiopharm Theranostics Ltd is a clinical-stage radiotherapeutics company focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. It develops and commercializes radiopharmaceutical platforms for therapeutic and diagnostic applications in precision oncology. The Company develops targeted and scientifically validated radiopharmaceutical technologies in pre-clinical and clinical stages. It has one reportable segment, being the research, development, and commercialization of health technologies. The Company operates in Australia and the United States, with maximum revenue from the United States.